Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35

被引:5
|
作者
Wei, Mengying [1 ,2 ]
Liu, Yuanyuan [1 ]
Pi, Zifeng [2 ]
Yue, Kexin [1 ]
Li, Shizhe [3 ]
Hu, Mingxin [1 ]
Liu, Zhiqiang [2 ]
Song, Fengrui [2 ]
Liu, Zhongying [1 ]
机构
[1] Jilin Univ, Sch Pharmaceut Sci, 1266 Fujin Rd, Changchun 130021, Jilin, Peoples R China
[2] Chinese Acad Sci, Changchun Inst Appl Chem, Natl Ctr Mass Spectrometry Changchun, Jilin Prov Key Lab Chinese Med Chem & Mass Spectr, Changchun 130022, Jilin, Peoples R China
[3] Guangdong Univ Technol, Inst Biomed & Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
ARACHIDONIC-ACID; NITRIC-OXIDE; FATTY-ACIDS; DEMENTIA; SYSTEMS; CHOLESTEROL; NEUROINFLAMMATION; HOMOCYSTEINE; INFLAMMATION; HIPPOCAMPUS;
D O I
10.1039/c9ra00302a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Alzheimer's disease (AD) has become one of the major diseases endangering the health of the elderly. Clarifying the features of each AD animal model is valuable for understanding the onset and progression of diseases and developing potential treatments in the pharmaceutical industry. In this study, we aimed to clarify plasma metabolomics and neurotransmitter dysfunction in the process of AD model rat induced by amyloid beta 25-35 (A beta 25-35). Firstly, Morris Water Maze (MWM) test was used to investigate cognitive impairment in AD rat after 2, 4 and 8 weeks of modelling. Based on this, the effects on levels of AD-related enzymes and eight neurotransmitters were analyzed. And plasma metabolomics analysis based on ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS) was used to research the metabolic disturbances in the process of AD rat. The results shown the injury on the spatial learning ability of AD rats was gradually aggravated within 4 weeks, reached the maximum at 4 weeks and then was stable until 8 weeks. During 8 weeks of modeling, the levels of enzymes including beta-secretase, gamma-secretase, glycogen synthase kinase-3 beta (GSK-3 beta), acetyl cholinesterase (AchE) and nitric oxide synthase (NOS) were significant increased in the plasma of AD rats. The neurotransmitter dysfunction was mainly involved in gamma-aminobutyric acid (GABA), acetyl choline (Ach), glutamic acid (Glu), 5-hydroxytryptamine (5-HT), dopamine (DA) and norepinephrine (NE). 17 endogenous metabolites correlated with AD were successfully detected in the metabolomics analysis. These metabolites were mainly involved in fatty acids, sphingolipids, and sterols metabolisms, vitamin metabolism, and amino acid metabolism. These metabolites might be the potential biomarkers that correctly mark different stages of AD. The study on peripheral plasma indices reflecting the process of AD laid the foundation for understand the pathophysiology of AD and find an effective and radical cure. And the rules of endogenous metabolic disorder in AD rats also have a certain guiding significance for the future study of food-drug interactions at different stages of AD.
引用
收藏
页码:18308 / 18319
页数:12
相关论文
共 50 条
  • [41] Coinjection of amyloid β peptide(25-35) and ibotenic acid does not create an animal model for Alzheimer's disease.
    Laksafoss, T
    Jorgensen, OS
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 93 - 93
  • [42] Neuroprotection by D-securinine against neurotoxicity induced by beta-amyloid (25-35)
    Xu, L
    Zhang, JT
    NEUROLOGICAL RESEARCH, 2004, 26 (07) : 792 - 796
  • [43] APOPTOSIS MEDIATED NEUROTOXICITY INDUCED BY CHRONIC APPLICATION OF BETA-AMYLOID FRAGMENT 25-35
    FORLONI, G
    CHIESA, R
    SMIROLDO, S
    VERGA, L
    SALMONA, M
    TAGLIAVINI, F
    ANGERETTI, N
    NEUROREPORT, 1993, 4 (05) : 523 - 526
  • [44] The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer's Disease
    Hillen, Heinz
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [45] Sulfadiazine Partially Protects the Rat Temporal Cortex from Amyloid Beta Peptide (25-35)-Induced Alterations of the Somatostatinergic System
    Burgos-Ramos, E.
    Puebla-Jimenez, L.
    Hernandez-Pinto, A.
    Arilla-Ferreiro, E.
    NEUROENDOCRINOLOGY, 2009, 89 (04) : 400 - 410
  • [46] FAILURE OF BETA-AMYLOID PROTEIN-FRAGMENT 25-35 TO CAUSE HIPPOCAMPAL DAMAGE IN THE RAT
    STEINBEHRENS, B
    ADAMS, K
    YEH, M
    SAPOLSKY, R
    NEUROBIOLOGY OF AGING, 1992, 13 (05) : 577 - 579
  • [47] Tumor necrosis factor-alpha aggravates hippocampal damage in rat induced by amyloid beta-peptide (25-35)
    Stepanichev, M
    Yakovlev, A
    Onufriev, M
    Lazareva, N
    Zarubenko, I
    Gulyaeva, N
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 20 - 20
  • [48] Amyloid-β(25-35)-induced memory impairments correlate with cell loss in rat hippocampus
    Stepanichev, MY
    Zdobnova, IM
    Zarubenko, II
    Moiseeva, YV
    Lazareva, NA
    Onufriev, MV
    Gulyaeva, NV
    PHYSIOLOGY & BEHAVIOR, 2004, 80 (05) : 647 - 655
  • [49] Mechanism of soluble beta-amyloid 25-35 neurotoxicity in primary cultured rat cortical neurons
    Wang, Yong
    Liu, Lili
    Hu, Weimin
    Li, Guanglai
    NEUROSCIENCE LETTERS, 2016, 618 : 72 - 76
  • [50] BETA-AMYLOID (BETA/A4) 25-35 INDUCES DEGENERATION OF MEDIAN BUT NOT DORSAL RAPHE NEURONS IN THE RAT
    LEE, JM
    HEJNA, G
    SIGURDSSON, E
    SINGH, S
    LORENS, SA
    FASEB JOURNAL, 1992, 6 (05): : A1916 - A1916